Publication | Closed Access

Co-delivery of oxygen and erlotinib by aptamer-modified liposomal complexes to reverse hypoxia-induced drug resistance in lung cancer

Hypoxia-induced Drug ResistanceAptamer-modified Liposomal ComplexesPolymer-drug ConjugateMedicineTumor TargetingAnti-cancer AgentPharmacologyRadiation OncologyLung Cancer